Back to search

Peptide record

TPDB22622

K17V] Latarcin-3a (5-17) [M5,13L Antibacterial Anticancer Toxicity standard
13 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB22622
K17V] Latarcin-3a (5-17) [M5,13L
Antibacterial Anticancer Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
Peptipedia DBAASP
standard
No
A 13-aa standard natural multi-activity (Antibacterial, Anticancer, and Toxicity) peptide sequence curated from Peptipedia and DBAASP, with an available 3D structural model.
Sequence
LAKKLKEYLEKLV
Physicochemical Analysis
C75H131N17O19
RNDCQGHIMFPSTW
LK
1574.97
9.97
4
2
7
+2
4.72
-0.208
150.00
Mammalian: 5.5 hour Yeast: 3 min E.coli: 2 min
1490
94.61
1
Residue Composition
number
1
A
0
R
0
N
0
D
0
C
2
E
0
Q
0
G
0
H
0
I
4
L
4
K
0
M
0
F
0
P
0
S
0
T
0
W
1
Y
1
V
Amino Acid Distribution
A: 1 R: 0 N: 0 D: 0 C: 0 E: 2 Q: 0 G: 0 H: 0 I: 0 L: 4 K: 4 M: 0 F: 0 P: 0 S: 0 T: 0 W: 0 Y: 1 V: 1
Chemical Descriptors
13
C75H131N17O19
1574.97
9.97
+2
4.72
-0.208
Evidence Records 3 records
Evidence 1 Activity

Activity

Toxicity
Hemolytic
NA | target cell: Mouse erythrocytes

Target

Mouse erythrocytes

Source & Reference

NA
DBAASP
First generation of multifunctional peptides derived from latarcin-3a from Lachesana tarabaevi spider toxin. | Front Microbiol | 2022
Evidence 2 Activity

Activity

Toxicity
Hemolytic Cytotoxic
Hemolytic_activity: Not available | Cytotoxicity: Not available

Target

erythrocytes

Source & Reference

NA
DRAMP
Front Microbiol. 2022 Sep 21 13:965621.
Evidence 3 Activity

Target

Cutibacterium acnes

Source & Reference

DBAASP